Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: PledPharma
Woman and Man Max 99 years
PledPharma AB
Update Il y a 4 ans
A local feasibility study of mangafodipir as an adjunct to percutaneous coronary intervention in patients with acute myocardial infarction
The main objective of the present trial is to find out whether mangafodipir, being a potent cardioprotective drug in animal studies, prevents reperfusion injury and reduces infarct size in patients du...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
PledPharma AB
Update Il y a 4 ans
A LOCAL FEASIBILITY STUDY ON MANGAFODIPIR AS AN ADJUNCT TO FOLFOX6 CHEMOTHERAPY IN PATIENTS OPERATED FOR COLORECTAL CANCER STAGE DUKE C (MANFOL)
The main objective of the present study is to find out whether pre-treatment with the compound mangafodipir lowers the frequency and/or severity of FOLFOX6-related haematological toxicity and neurosen...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
PledPharma
Update Il y a 4 ans
Étude POLAR-M : étude de phase 3 randomisée évaluant l’efficacité du calmangafodipir associé à une chimiothérapie FOLFOX6 modifié (5-fluorouracile, acide folique et oxaliplatine), dans la prévention de la neuropathie périphérique induite par une chimiothérapie de 1re ligne, chez des patients ayant un cancer colorectal métastasique.
La neuropathie périphérique liée aux chimiothérapies à base d’oxaliplatine est un problème majeur de toxicité car elle cause une altération parfois conséquente de la qualité de vie des patients. Les ...
Country
France
organs
Tout Cancer
Specialty
Chimiothérapie
,
Autres (cryothérapie, radiofréquence, homéopathie,...)
Essai ouvert aux inclusions
More information
Woman and Man Max 99 years
PledPharma AB
Update Il y a 4 ans
A Phase II Trial of PledOx in combination with the cancer theraphy FOLFOX6 in patients with cancer in the large inestine
Primary Objective Dose Escalation Phase: To characterize the prevalence, severity, drug-relatedness and seriousness of adverse events of PledOx in two doses Primary Objective Randomised Treatment Ph...
Country
None
organs
None
Specialty
None
Closed trial
More information